CEO Spotlight: Frank Cheng, Caristo Diagnostics
Caristo's Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one of Oxford's most exciting companies.
Caristo's Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one of Oxford's most exciting companies.
Beacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive £96 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
Take a glimpse into the future with startups emerging from OUI’s incubator.
The 2023 Spotlight on Spinouts report once again underlines Oxford’s leading position in spinout creation. The report underlines Oxford Science Enterprises’ positive impact on Oxford’s spinout community, while investments into Oxford spinouts remain high, despite UK-wide downturn.
The University of Oxford partners with top universities and investors to agree terms which will greatly increase the UK’s capacity to turn world-leading research into spinouts that will generate economic growth and societal impact.
With companies created ranging from AI and quantum computing to vaccine developers and social ventures tackling poverty, Oxford University hits milestone in company creation, cementing its status as a leading institution in research commercialisation globally.
Lumai, a spinout from the University of Oxford, has secured a £1.1m Innovate UK Smart Grant to develop all-optical neural networks for high-performance computing and machine vision. The grant will help Lumai develop its vision to build ONNs that could be the solution to the explosive increase in computational demand to support breakthrough AI models such as ChatGPT.
Quantum Motion, an Oxford firm making quantum computers on silicon a reality, is riding high after a £42m funding round. To find out more, OUI's Gregg Bayes-Brown spoke with QM’s CEO James Palles-Dimmock.